Dopavision gibt Update zur klinischen Studie mit MyopiaX® bekannt; alle Studienzentren aktiv
June 28, 2023 04:00 ET
|
AKAMPION
- Klinische Erprobung von MyopiaX®, dem ersten Ansatz zur digitalen Behandlung von Kurzsichtigkeit bei Kindern beruhend auf dem Dopamin-Signalweg - Aufnahme von Patienten in Deutschland, Spanien,...
Dopavision proporciona información actualizada sobre los ensayos clínicos y anuncia que todos los centros del ensayo MyopiaX-1 están activos
June 28, 2023 04:00 ET
|
AKAMPION
- Primer ensayo clínico en humanos de MyopiaX® , el primer enfoque terapéutico para la miopía juvenil dirigido digitalmente a la vía dopaminérgica.- Inscripción en curso en Alemania, España, Países...
Dopavision Provides Clinical Trial Update and Announces All MyopiaX-1 Trial Sites Are Active
June 28, 2023 04:00 ET
|
AKAMPION
- First-in-human clinical trial of MyopiaX®, the first therapeutic approach in juvenile myopia to target the dopamine pathway digitally- Enrollment ongoing in Germany, Spain, the Netherlands, and the...
Growth Report: Digital Therapeutics Market Worth $18 Billion, Globally, by 2028 at 23.1% CAGR | The Insight Partners
June 21, 2023 10:26 ET
|
The Insight Partners
Pune, India, June 21, 2023 (GLOBE NEWSWIRE) -- According to our latest study on "Digital Therapeutics Market Size Report, Forecast to 2028 – COVID-19 Impact and Global Analysis – by Application, and...
U.S. Digital Therapeutics Market Worth $21.46 Billion by 2030: Coherent Market Insights
June 15, 2023 09:02 ET
|
CMI
Burlingame, June 15, 2023 (GLOBE NEWSWIRE) -- The U.S. digital therapeutics market size is estimated to reach USD 21.46 billion by 2030, expanding at a CAGR of 33.8% from 2023 to 2030, according to...
Global Digital Therapeutics [DTx] for Mental Health Market Size
June 08, 2023 08:00 ET
|
Global Market Estimates
Brooklyn, New York, June 08, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Digital Therapeutics for Mental Health Market is...
Unlock the Future of Healthcare: Digital Therapeutics Alliance Inaugural Summit to Empower DTx Industry Leaders and Policymakers
May 11, 2023 13:04 ET
|
Digital Therapeutics Alliance
Arlington, VA, May 11, 2023 (GLOBE NEWSWIRE) -- Digital Therapeutics Alliance (DTA) is proud to announce its Inaugural Summit, to be held June 7-9, 2023 at the Washington D.C. Marriott at Metro...
Wellthy Therapeutics Announces Expansion into the United States - Completes FDA CFR Part 11, FDA CFR Part 820, and HIPAA Certification for Its Platform
May 11, 2023 09:00 ET
|
WELLTHY THERAPEUTICS PRIVATE LIMITED
MUMBAI and LOS ANGELES, May 11, 2023 (GLOBE NEWSWIRE) -- Wellthy Therapeutics, a global leader in digital health and digital therapeutics, announces the successful completion of its FDA 21 CFR Part...
atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates
May 11, 2023 06:59 ET
|
atai Life Sciences
RL-007: First patient dosed in the Phase 2b study of RL-007 in Cognitive Impairment Associated with Schizophrenia.GRX-917: Presented PD data from the completed Phase 1 study, which suggest the...
Feel Therapeutics Selected to Join Johnson & Johnson Innovation–JLABS to Catalyze their Vision of Digital Precision Medicine in Mental Health
May 09, 2023 08:30 ET
|
Feel Therapeutics
SAN FRANCISCO, May 09, 2023 (GLOBE NEWSWIRE) -- Feel Therapeutics, a leading digital precision medicine company, is proud to announce that it has been accepted into Johnson & Johnson...